1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. HALOZYME THERAPEUTICS INC.
Halozyme Therapeutics Inc. XNAS: HALO
Strong Performer, Getting Expensive
Download real time
74.93 1.53 (2.08%)
New 52W High in past week
1.9M
XNAS Volume

XNAS 05 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Halozyme Therapeutics Inc. is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details

Halozyme Therapeutics Inc. - HALO - stock price prediction, stock price target, analyst ratings from 9 analysts

Halozyme Therapeutics Inc. has a share price target of US$ 71, revenue growth forecast of 30.0%, and profit growth estimate of 53.3% for FY25, based on top 9 analyst calls.

Forecaster Screeners